Avior Wealth Management’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Avior Wealth Management’s Portfolio BXRX Stock Details BXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	–	–	3884
2023 Q4	$0	Hold	1	–	–	﹤0.01%	1691
2023 Q3	$0	Buy	+1	New	+$1	﹤0.01%	1694

Avior Wealth Management's BXRX Position: Q1 2024 in Review

Avior Wealth Management sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q1 2024, closing a stake of 1 share.

Avior Wealth Management first reported a position in BXRX in Q3 2023 and held it in 2 quarters. The position peaked at $0 in Q4 2023. 1 fund tracked by Wall St. Rank holds BXRX as of Q1 2024.

Avior Wealth Management reported no remaining Baudax Bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Avior Wealth Management sold 1 Baudax Bio, Inc. Common Stock share in Q1 2024.
Avior Wealth Management first reported a position in Baudax Bio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Avior Wealth Management's Baudax Bio, Inc. Common Stock position peaked at $0 in Q4 2023.
1 fund tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q1 2024.

Based on Avior Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.